Camila Canaán-Haden | Biomedical research | Best Researcher Award

Posted on by ScienceFather

Ms. Camila Canaán-Haden | Biomedical research | Best Researcher Award

PhD student, Center for Genetic Engineering and Biotechnology (CIGB)

Camila Canaán-Haden Ayala is a Cuban researcher specializing in cancer immunotherapy. She works at the Center for Genetic Engineering and Biotechnology (CIGB), focusing on developing therapeutic cancer vaccines and recombinant antigen production. Her expertise includes immune response evaluations using ELISA, FACS, ELISPOT, and cytokine assays in various models. She has contributed to COVID-19 clinical trials and vaccine development, including the Abdala vaccine. Camila has undertaken multiple international research fellowships in Italy, Spain, France, and Mexico. Her work aims to improve immunotherapeutic strategies against cancer by targeting immune checkpoints and optimizing vaccine efficacy.

Profile

Scholar

🎓 Education

Camila holds a Master’s in Contemporary Biotechnology (2019-2022) from CIGB and a Bachelor’s in Biochemistry and Molecular Biology (2012-2017) from the University of Havana. She completed postgraduate training in bioinformatics, immunology, protein engineering, and good laboratory practices. Her academic foundation includes mathematics, chemistry, molecular genetics, virology, and clinical biochemistry. She has pursued advanced studies in biomedical research through multiple international pre-doctoral fellowships.

💼 Experience

Since 2017, Camila has been a researcher at CIGB’s Cancer Immunotherapy Lab. She has led projects on immune checkpoint inhibition strategies and therapeutic cancer vaccine development. Her work includes antigen cloning, protein characterization, and immunogenicity studies in animal models. She has evaluated antitumor and anti-metastatic effects of novel therapies and contributed to clinical trials for COVID-19 treatments. She has also worked with antibody phage display libraries to develop scFv antibodies. Her research extends to immune response assessments for cancer and infectious disease vaccines.

🏆 Awards & Honors

Camila has received prestigious short-term pre-doctoral fellowships in Italy (ICGEB-Trieste, University of Padua), Spain (CIBIR), France (Cancer Research Center of Lyon), and Mexico (CICESE), funded by international programs like IILA, Coimbra Group, and EU Ventana Adelante. Her contributions to COVID-19 vaccine research have been recognized in published scientific papers. She has played a key role in Cuban clinical trials for novel immunotherapies and has received funding for advanced research in biotechnology and immunology.

🔍 Research Focus

Camila’s research centers on cancer immunotherapy, focusing on immune checkpoint inhibition and tumor vaccine development. She specializes in recombinant antigen production, immune response characterization, and antibody-based therapies. Her projects involve antigen cloning, protein engineering, and evaluating vaccine efficacy in preclinical models. She has explored the combination of immunotherapies targeting VEGF and PD-L1 pathways to enhance anti-tumor responses. Her work has also contributed to COVID-19 vaccine research, particularly in evaluating immunogenicity and antibody responses.

Conclusion

Camila Canaán-Haden Ayala’s academic and professional trajectory is exceptional, with significant contributions to cancer immunotherapy and vaccine development. Her technical expertise, international exposure, and scientific output make her a strong contender for the Best Researcher Award. With a continued focus on expanding her clinical research impact, publishing in high-impact journals, and taking on leadership roles, her potential to drive groundbreaking innovations is evident.

Publication

M Limonta-Fernández, G Chinea-Santiago, AM Martín-Dunn, …
Title: An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen
Year: 2022
Citation: 63

LA Espinosa, Y Ramos, I Andújar, EO Torres, G Cabrera, A Martín, …
Title: In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2
Year: 2021
Citation: 15

YA Fleites, J Aguiar, Z Cinza, M Bequet, E Marrero, M Vizcaíno, I Esquivel, …
Title: HeberNasvac, a therapeutic vaccine for chronic hepatitis B, stimulates local and systemic markers of innate immunity: Potential use in SARS-CoV-2 postexposure prophylaxis
Year: 2021
Citation: 10

LA Espinosa, Y Ramos, I Andújar, EO Torres, G Cabrera, A Martín, …
Title: In-solution buffer-free digestion for the analysis of SARS-CoV-2 RBD proteins allows a full sequence coverage and detection of post-translational modifications in a single ESI
Year: 2021
Citation: 8

Y Morera-Díaz, C Canaán-Haden, J Sánchez-Ramírez, …
Title: Active immunization with a structurally aggregated PD-L1 antigen breaks T and B immune tolerance in non-human primates and exhibits in vivo anti-tumoral effects in
Year: 2023
Citation: 4

D Vázquez-Blomquist, M Bequet-Romero, Y Mendoza-Marí, G Lemos, …
Title: Nasalferon, a new nasal formulation of IFNα2b, modulates cellular and molecular elements associated with an antiviral response in mucosa and blood
Year: 2022
Citation: 4

EM Idelsis, PE Jésus, DR Yaquelin, VB Dania, BR Mónica, BR Lisandra, …
Title: A combination treatment of IFN-α2b and IFN-γ accelerates viral clearance and control inflammatory response in COVID-19: Preliminary results of a randomized controlled trial
Year: 2021
Citation: 4

C Canaán-Haden, J Sánchez-Ramírez, R Martínez-Castillo, …
Title: Immunogenicity and Safety Profile of Two Adjuvanted-PD-L1-Based Vaccine Candidates in Mice, Rats, Rabbits, and Cynomolgus Monkeys
Year: 2025
Citation: N/A

Y Morera, M Bequet-Romero, F Hernández-Bernal, I González-Moya, …
Title: Preclinical and clinical significance of VEGF deprivation in ovarian cancer through a specific active immunotherapy
Year: 2023
Citation: N/A

Abdulwasiu Ibrahim | Drug Discovery | Young Scientist Award

Posted on by ScienceFather

Mr. Abdulwasiu Ibrahim | Drug Discovery | Young Scientist Award

Research Fellow, Drosophila Research and Training Centre Nigeria

Abdulwasiu Ibrahim is a biochemist specializing in cancer biology, molecular biology, and bioinformatics. He is affiliated with the Department of Biochemistry, University of Ibadan, Nigeria. His expertise spans drug discovery, precision medicine, pharmacogenomics, and toxicogenomics. Proficient in computational biology, he applies computer-aided drug design, immunoinformatics, and biochemical analytics to research. His technical skills include gel electrophoresis, ELISA, PCR, and spectroscopy. He has a strong background in statistical analysis using GraphPad Prism and Microsoft Excel, with foundational knowledge of Python. He has extensive research experience in genetic profiling and biological drug delivery. Currently, he is a Research Fellow at the Drosophila Research and Training Centre and a Research Associate at the Institute of Bioinformatics and Molecular Therapeutics. He has received multiple conference fellowships and published several high-impact research papers. His work contributes to advancing cancer treatment and precision medicine using bioinformatics and molecular biology approaches.

Publication Profile

Oricd

🎓 Education

Master of Science in Biochemistry (Cancer Research and Molecular Biology) – University of Ibadan, Nigeria (2022–2024) Thesis: Interactive Toxicity of 2-Acetylaminoflourene and Diethylnitrosamine in Drosophila melanogaster. Bachelor of Science in Biochemistry (Second Class Upper-Honours) – Usmanu Danfodiyo University, Sokoto, Nigeria (2015–2019)
Thesis: Analgesic Activity of n-Hexane Extract of Castor Seed on Formalin-Induced Pain in Albino Rats.

💼 Experience

Research Fellow – Drosophila Research and Training Centre (2022–Present) Designed and conducted Drosophila experiments, supervised students, and managed lab operations.. Research Associate (Volunteer) – Institute of Bioinformatics and Molecular Therapeutics (2022–Present) Developed computational models for drug discovery, performed molecular docking, and trained interns. Post-Graduate Research Assistant – University of Ibadan (2022–2024) Conducted molecular analysis of cancer markers and supervised undergraduate projects. Research Assistant – Drosophila Laboratory, University of Ibadan (2021–2022) Taught students Drosophila research techniques and performed oxidative stress biomarker analysis. Undergraduate Research Assistant – Usmanu Danfodiyo University (2019–2020) Conducted phytochemical screening, biochemical analysis, and systematic reviews. Tutorial Teacher – Nigerian Society of Biochemistry Students (2019) Taught biochemistry, pharmacology, and molecular biology to undergraduate students.

🏆 Awards & Honors

Conference Fellowships: 11th & 10th Conference of the Nigerian Institute of Medical Research (NIMR) (2022, 2021) 2nd Drug Discovery Africa International Conference (DDA) (2022) 2nd Conference of Nigerian Bioinformatics and Genomics Network (NBGN) (2021) 7th Unibadan Conference of Basic Medical Sciences (2021). Virtual Chair Award – Midwest Drosophila Conference (2022). Pre-Conference Workshops: Genotyping with TaqMan and Real-Time PCR Bioinformatics and Genome-Wide Association Studies Summer School: Hands-on training in bioinformatics and drug discovery. Best Paper Presentation: Nigerian Society of Biochemistry and Molecular Biology Conference (2021) Recognized for contributions to Drosophila biomedical research and computational drug design.

🔍 Research Focus

Cancer Biology & Genomics: Investigating genetic markers and molecular pathways in cancer progression. Molecular Biology & Bioinformatics: Computational modeling of biomolecules and genome-wide association studies. Drug Discovery & Design: Using in silico techniques to identify potential drug candidates for cancer and neurodegenerative diseases. Precision Medicine & Genetic Profiling: Exploring personalized treatment approaches through pharmacogenomics. Pharmacogenomics & Toxicogenomics: Studying drug responses and toxic effects at the genetic level. Biological Drug Delivery: Developing targeted therapies using nanoformulations and bioactive compounds. Computational Biology: Expertise in homology modeling, molecular docking, virtual screening, and molecular dynamics simulations. Laboratory Techniques: Skilled in gel electrophoresis, ELISA, PCR, spectrophotometry, and tissue imaging.

Publication Top Notes

  • Computational Investigation of Polo-like Kinase 1 (PLK1): Inhibitive Potential of Benzimidazole-Carbonamide Derivatives for Cancer Treatment
    • Year: 2024
    • Authors: Ipinloju, N.; Balogun, T.A.; Ibrahim, A.; Adeyemo, M.A.; Esan, T.O.; Emmanuel, A.V.; Bello, K.A.; Omiyeniyi, G.D.; Oyeneyin, O.E.
    • Citation: Physical Chemistry Research
    • Link: DOI: 10.22036/pcr.2023.377616.2331

 

  • Identification of Phytochemicals with Inhibitory Potential Against Beta-lactamase Enzymes via Computer-aided Approach
    • Year: 2024
    • Authors: Nwokebu, G.C.; Adesina, A.B.; Isibor, C.N.; Aigbepue, S.A.; Egbo, C.C.; Pureaziba, N.; Isaac, O.O.; Owolade, A.J.-J.; Alabere, H.O.; Iwuagwu, M.O.
    • Citation: Bioorganic Chemistry
    • Link: DOI: 10.1016/j.bioorg.2024.107238

 

  • Insight into the Corrosion Inhibiting Potential and Anticancer Activity of 1-(4-methoxyphenyl)-5-methyl-N’-(2-oxoindolin-3-ylidene)-1H-1,2,3-triazole-4-carbohydrazide via Computational Approaches
    • Year: 2024
    • Authors: Oluwatoba Emmanuel Oyeneyin; Abdulwasiu Ibrahim; Nureni Ipinloju; Adeniyi John Ademoyegun; Nathanael Damilare Ojo
    • Citation: Journal of Biomolecular Structure and Dynamics
    • Link: DOI: 10.1080/07391102.2023.2260491

 

  • Plant-derived Extracellular Vesicles as Potential Smart Nano Drug Delivery Systems for Antioxidant Vitamins C and E in Alzheimer’s Disease
    • Year: 2024
    • Authors: Amina Jiyah; Suleiman Alhaji Muhammad; Abdulwasiu Ibrahim; Ibrahim Bulama; Abdullahi Ibrahim; Abdullahi Yahya Abbas; Mustapha Umar Imam; Yusuf Saidu; Lawal Suleiman Bilbis
    • Citation: Journal of Drug Delivery Science and Technology
    • Link: DOI: 10.1016/j.jddst.2024.105618

 

  • Identification of Potential Acetylcholinesterase (AChE) Inhibitors from Vitis Vinifera: A Case Study of Alzheimer’s Disease (AD)
    • Year: 2023
    • Authors: Sofela, S.O.; Ibrahim, A.; Bodun, D.S.; Nwankwo, D.O.; Mafimisebi, M.; Abdulrasheed, B.; Balogun, T.; Opeyemi, I.
    • Citation: Research Square
    • Link: DOI: 10.21203/rs.3.rs-3342491/v1

 

  • Quantum Evaluation and Therapeutic Activity of (E)-N-(4-methoxyphenyl)-2-(4-(3-oxo-3-phenylprop-1-en-1-yl) phenoxy)acetamide and Its Modified Derivatives Against EGFR and VEGFR-2 in the Treatment of Triple-negative Cancer via In Silico Approach
    • Year: 2023
    • Authors: Ipinloju, N.; Ibrahim, A.; da Costa, R.A.; Adigun, T.B.; Olubode, S.O.; Abayomi, K.J.; Aiyelabegan, A.O.; Esan, T.O.; Muhammad, S.A.; Oyeneyin, O.E.
    • Citation: Journal of Molecular Modeling
    • Link: DOI: 10.1007/s00894-023-05543-2

 

  • Discovery of Potential Phytochemicals from Carica Papaya Targeting BRCA-1 in Breast Cancer Treatment
    • Year: 2023
    • Authors: Abdulwasiu Ibrahim; Nureni Ipinloju; Abdulsamad Omotayo Aiyelabegan; Abdulbaki Adio Alfa-Ibrahim; Suleiman Alhaji Muhammad; Oluwatoba Emmanuel Oyeneyin
    • Citation: Applied Biochemistry and Biotechnology
    • Link: DOI: 10.1007/s12010-023-04473-2

 

  • Discovery of Small Molecule PARKIN Activator from Antipsychotic/Anti-neuropsychiatric Drugs as Therapeutics for PD: An In Silico Repurposing Approach
    • Year: 2023
    • Authors: Abdulwasiu Ibrahim; Nureni Ipinloju; Nkechi Hope Atasie; Rahmotallah Mosunmola Babalola; Suleiman Alhaji Muhammad; Oluwatoba Emmanuel Oyeneyin
    • Citation: Applied Biochemistry and Biotechnology
    • Link: DOI: 10.1007/s12010-023-04376-2

 

  • Computational Evaluation of Azadirachta Indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer’s Disease
    • Year: 2023
    • Authors: Ishabiyi FO; Ogidi J; Olukade BA; Amorha CC; El-Sharkawy LY; Okolo CC; Adeniyi TM; Atasie NH; Ibrahim A.; Balogun TA
    • Citation: Journal of Alzheimer’s Disease (JAD)
    • Link: DOI: 10.3233/jad-221020

 

  • Discovery of Small Molecule PARKIN Activator as Therapeutics for PD: An In-silico Repurposing Approach
    • Year: 2022
    • Authors: Abdulwasiu Ibrahim; Nureni Ipinloju; Suleiman Alhaji Muhammad; Oluwatoba Emmanuel Oyeneyin; Nkechi Hope Atasie
    • Citation: Preprint
    • Link: DOI: 10.21203/rs.3.rs-2035291/v1

 

  • Antioxidant-Rich Nutraceutical as a Therapeutic Strategy for Sickle Cell Disease

 

Merve Keskinkilic | Medical Oncology | Best Researcher Award

Posted on by ScienceFather

Dr. Merve Keskinkilic | Medical Oncology | Best Researcher Award

Medical Oncologist, Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital Turkey

Merve Keskinkılıç is a dedicated Medical Oncologist at Burdur State Hospital with a strong academic background in Internal Medicine and Medical Oncology. She earned her M.D. from Dokuz Eylul University Faculty of Medicine and completed her Medical Oncology Fellowship at the same institution. Dr. Keskinkılıç has extensive clinical experience, having served as a Research Fellow at Emory University, USA. Fluent in English (C1 Advanced) and proficient in German (Elementary), she actively participates in international oncology research. Her expertise includes clinical trials, cancer treatment strategies, and translational oncology research, contributing significantly to advancements in the field.

Publication Profile

Scopus

Scholar

🎓 Education

Dr. Keskinkılıç completed her high school education at Balıkesir Science High School (2004-2008) before pursuing medicine at Dokuz Eylul University (2008-2014). She participated in an Oncology Exchange Program at Mansoura University, Egypt (2010). She later obtained an Associate Degree in Healthcare Management from Anadolu University (2014-2017). Her residency in Internal Medicine was completed at Celal Bayar University (2015-2016) and Dokuz Eylul University (2016-2019). She pursued a Medical Oncology Fellowship at Dokuz Eylul University (2019-2024) and is currently undertaking a PhD in Basic Oncology at Dokuz Eylul University Oncology Institute (since 2022). She also worked as a Research Fellow at Emory University, USA (2023).

💼 Experience

Dr. Keskinkılıç began her career as a General Practitioner at Balıkesir Susurluk State Hospital (2014-2015) before becoming a Research Assistant in Internal Medicine at Celal Bayar University (2015-2016) and later at Dokuz Eylul University (2016-2019). She served as a Specialist Doctor at Bitlis Mutki State Hospital (2019) and as a Fellow in Medical Oncology at Dokuz Eylul University (2019-2024). Currently, she is a Medical Oncologist at Burdur Public Hospital (2024-2025) and will join Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital in 2025.

🏆 Awards & Honors

Dr. Keskinkılıç holds several prestigious certifications, including the Turkish Board of Internal Medicine Certificate (2018), Experimental Animal Use Certificate (2019), Oncology Clinical Research Training Certificate (2020), and ESMO Board of Examination Certificate (2023). She has also completed Good Clinical Practices (ICU) and Clinical Research Training and has received certifications in Research Ethics and Clinical Trials. Her contributions to oncology research and education have been recognized through multiple national and international accolades.

🔬 Research Focus

Dr. Keskinkılıç specializes in clinical oncology research, focusing on urothelial, bladder, gastric, prostate, and lung cancers. She is actively involved in multiple clinical trials, serving as a Sub-Investigator in research projects such as THOR (Urothelial Cancer), Niagara (Bladder Cancer), MK3475-859 (Gastric Cancer), Regeneron (Non-Small Cell Lung Cancer), and Radiant 20510 (Prostate Cancer). Her work emphasizes innovative treatment strategies, immunotherapy, and targeted cancer therapies, contributing to the development of advanced oncological treatments. Her internal medicine dissertation evaluated CMV DNA Antigenemia in Allogeneic Bone Marrow Transplant Patients.

Publication Top Notes

  • Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
    • Authors: C. Karacin, B. Oksuzoglu, A. Demirci, M. Keskinkılıç, et al.
    • Journal: BMC Cancer, 2023
    • Citations: 20

 

  • Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
    • Authors: S. Kahraman, E. Erul, M. Seyyar, O. Gumusay, et al.
    • Journal: Future Oncology, 2023
    • Citations: 13

 

  • Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: a multicenter study
    • Authors: H. Ç. Yıldırım, E. Mutlu, E. Chalabiyev, M. Özen, et al.
    • Journal: The Breast, 2022
    • Citations: 13

 

  • The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor-positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and…
    • Authors: E. C. Yildirim, E. Atag, E. Coban, et al.
    • Journal: The Breast, 2023
    • Citations: 12

 

  • Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia
    • Authors: H. C. Yildirim, C. Kapar, B. Koksal, et al.
    • Journal: Journal of Chemotherapy, 2024
    • Citations: 4

 

  • The prognostic indicator in breast cancer treated with CDK4/6 inhibitors: the prognostic nutritional index
    • Authors: M. Keskinkilic, H. S. Semiz, G. Polat, et al.
    • Journal: Future Oncology, 2023
    • Citations: 4

 

  • Antibody-Drug Conjugates in Triple Negative Breast Cancer
    • Authors: M. Keskinkilic, R. Sacks
    • Journal: Clinical Breast Cancer, 2024
    • Citations: 3

 

  • 194P Increased blood creatinine level due to CDK 4/6 inhibitor treatments: single center experience
    • Authors: M. Keskinkılıç, H. S. Semiz, T. Yavuzsen, A. Karaoglu
    • Journal: Annals of Oncology, 2022
    • Citations: 3

 

  • The prognostic nutritional index (PNI): A new biomarker for determining prognosis in metastatic castration-sensitive prostate carcinoma
    • Authors: H. I. Ellez, M. Keskinkilic, et al.
    • Journal: Journal of Clinical Medicine, 2023
    • Citations: 11

 

  • The role of immune checkpoint inhibition in triple-negative breast cancer
    • Authors: K. Tarekegn, M. Keskinkilic, T. J. Kristoff, S. T. Evans, K. Kalinsky
    • Journal: Expert Review of Anticancer Therapy, 2023
    • Citations: 10

 

  • The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer
    • Authors: M. Hizal, B. Bilgin, N. Paksoy, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2023
    • Citations: 5

 

  • CD47 (‘don’t eat me’ signal) expression levels and its relationship with clinicopathologic features in early‐stage prostate carcinoma
    • Authors: H. S. Semiz, Ü. Küçük, E. Kısa, M. Keskinkılıç, et al.
    • Journal: The Prostate, 2022
    • Citations: 5

 

  • A severe case of levothyroxine intoxication successfully treated in intensive care unit
    • Authors: Y. Savran, T. Mengi, M. Keskinkilic
    • Journal: Journal of Acute Disease, 2018
    • Citations: 11

 

 

Ashwani Patil | Cancer Biology | Best Scholar Award

Posted on by ScienceFather

Dr. Ashwani Patil | Cancer Biology | Best Scholar Award

Assistant Professor, Dr. D. Y. Patil Institute of Pharmaceutical Sciences & Research India

Dr. Ashwani Patil is a passionate pharmacologist specializing in neurological disorders and cancer research. He completed his Ph.D. in Pharmacology from the Institute of Chemical Technology (ICT), Mumbai, with a focus on preclinical drug development. His research at Bhabha Atomic Research Centre and NIRRH Mumbai deepened his expertise in molecular mechanisms underlying complex diseases. With hands-on experience in animal handling, molecular techniques, and pharmacological testing, he has contributed significantly to understanding disease pathology and potential therapeutic targets for cancer and neurological disorders.

Professional Profile 

Scopus

Scholar

🎓Education

Ph.D. in Pharmaceutical Tech. (Pharmacology), Institute Of Chemical Technology, Mumbai (2024). M. Pharmacy (Pharmacology), R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur (2018). Bachelor of Pharmacy, A.R.A College of Pharmacy, Dhule (2016)

💼Experience

Junior Research Fellow, R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur (2018-2019). Research Scholar, Institute of Chemical Technology, Mumbai (2022-Present). Assistant Professor, Dr. D Y Patil Institute of Pharmaceutical Science and Research, Pune (2019-2020, 2024). Expertise in preclinical drug studies, rodent surgery, data analysis, and project planning.

🏆Award and Honor

DAE-ICT Fellowship, 2024. 1st Position in Poster Presentation, 7th International Conference on “Emerging Trends in Drug Development and Delivery” (2024). Research Excellence Award, GEU, Dehradun (2015). Best Paper Presentation Award, TriboIndia 2023, NIT Srinagar

🔬 Research Focus

Dr. Patil’s research spans preclinical drug development, focusing on neurological disorders and cancer. His work investigates therapeutic targets, pharmacodynamics, and the molecular mechanisms of disease pathology. Key areas of interest include rodent models, drug efficacy, safety profiles, and mitochondrial toxicity. His publications highlight cancer cell cytotoxicity and cardioprotective effects, contributing to the understanding of pharmacological agents in disease treatment.

Publications Top Noted

1. Title: Cardioprotective effect of CB1 receptor antagonist AM251 against β receptor-stimulated myocardial infarction via modulation of NF-kB signaling pathway in diabetic mice

Year: 2024
Authors: Pawar, H.D., Patil, Y., Patil, A., Ojha, S., Goyal, S.N.
Citation: Heliyon, 10(15), e35138
Citations: 0

2. Title: Mitochondria-targeted derivative of pterostilbene, a dietary phytoestrogen, exhibits superior cancer cell cytotoxicity via mitochondrial superoxide mediated induction of autophagy

Year: 2023
Authors: Ibrahim, M.K., Nandha, S.R., Patil, A.S., Sharma, D., Sandur, S.K.
Citation: Advances in Redox Research, 8, 100071
Citations: 1

3. Title: Mitochondriotropic Derivative of Ethyl Ferulate, a Dietary Phenylpropanoid, Exhibits Enhanced Cytotoxicity in Cancer Cells via Mitochondrial Superoxide-Mediated Activation of JNK and AKT Signalling

Year: 2023
Authors: Patil, A.S., Ibrahim, M.K., Sathaye, S., Sharma, D., Sandur, S.K.
Citation: Applied Biochemistry and Biotechnology, 195(3), 2057–2076
Citations: 2

4. Title: Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review

Year: 2020
Authors: Patil, A.S., Mahajan, U.B., Agrawal, Y.O., Sharma, C., Goyal, S.N.
Citation: Biomedicine and Pharmacotherapy, 132, 110889
Citations: 17

5. Title: Protective effect of omeprazole and lansoprazole on β-receptor stimulated myocardial infarction in Wistar rats

Year: 2019
Authors: Patil, A.S., Singh, A.D., Mahajan, U.B., Ojha, S., Goyal, S.N.
Citation: Molecular and Cellular Biochemistry, 456(1-2), 105–113
Citations: 17

 

Anubha Dey | Computational Biology | Best Researcher Award

Posted on by ScienceFather

Ms. Anubha Dey | Computational Biology | Best Researcher Award

 PHD, University of Hyderabad India

Anubha Dey is a dedicated Ph.D. researcher at the University of Hyderabad with a strong background in computational biology and machine learning. She has contributed significantly to understanding genetic interactions and cancer research through advanced modeling techniques. With a passion for teaching and mentoring, Anubha aspires to inspire future leaders in scientific innovation.

Professional Profile 

Scopus

Scholar

🎓Education

Ph.D. (Pursuing), University of Hyderabad, 2019-present. Master of Technology, Anna University, 2017-2019. Bachelor of Technology, Maulana Abul Kalam Azad University of Technology, West Bengal

💼Experience

Researcher: Developing machine learning models for cancer biology and genetic interactions. Assistant System Engineer-Trainee, Tata Consultancy Services, 2016-2017. Presented findings at renowned conferences like ICGA and CSHL

🏆Award and Honor

Best Oral Presentation, BioAnveshna 2024. Best Poster Presentation, International Cancer Symposium 2022. Selected for HySci 2024 Oral Talk, IIT Hyderabad. Qualified JEST 2019, a prestigious entrance test

🔬 Research Focus

Machine learning in genetic interaction prediction. Synthetic lethal interactions in cancer. Transcript complexity and RNA splicing. Chromatin loop dynamics and epigenetics

Publications Top Noted

  • Title: Chromatin loop dynamics during cellular differentiation are associated with changes to both anchor and internal regulatory features
    Year: 2023
    Authors: ML Bond, ES Davis, IY Quiroga, A Dey, M Kiran, MI Love, H Won
    Citation: Genome Research 33 (8), 1258-1268

 

  • Title: Inefficient splicing of long non-coding RNAs is associated with higher transcript complexity in human and mouse
    Year: 2023
    Authors: K Basu, A Dey, M Kiran
    Citation: RNA Biology 20 (1), 563-572

 

  • Title: MAGICAL: A multi-class classifier to predict synthetic lethal and viable interactions using protein-protein interaction network
    Year: 2024
    Authors: A Dey, S Mudunuri, M Kiran
    Citation: PLOS Computational Biology 20 (8), e1012336

 

  • Title: CaTCH: Calculating transcript complexity of human genes
    Year: 2024
    Authors: K Koushiki Basu, Anubha Dey
    Citation: Methodx

 

 

Ensiyeh Jenabi | Medicine| Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Ensiyeh Jenabi | Medicine| Best Researcher Award

Assistant Professor, Hamadan University of Medical Sciences, Iran

Ensiyeh Jenabi is an Iranian researcher and academic in midwifery, specializing in reproductive health. With a B.Sc. and M.Sc. in Midwifery from Hamadan and Tabriz Universities, respectively, she earned her Ph.D. in Reproductive Health from Hamadan University of Medical Sciences. Dr. Jenabi currently serves as a faculty member, teaching research methods and menopause courses at both MSc and PhD levels since 2017. She is an active member of the Autism Spectrum Disorders Research Center and the Mother and Child Care Research Center at Hamadan University of Medical Sciences, contributing to advancements in women’s health. 🌍💡

Publication Profile

Google Scholar

🎓 Education

B.Sc. in Midwifery, Hamadan University of Medical Sciences 🇮🇷. M.Sc. in Midwifery, Tabriz University of Medical Sciences 🇮🇷. Ph.D. in Reproductive Health, Hamadan University of Medical Sciences

💼 Experience

Faculty Member, Hamadan University of Medical Sciences, since 2017 . Researcher, Autism Spectrum Disorders Research Center, since 2018.  Researcher, Mother and Child Care Research Center, since 2018 . Member, Research in Education Committee at EDC, Hamadan University, since 2018 .

🏆 Awards & Honors

Recognized for outstanding research contributions in reproductive health.  Awarded various academic grants for research on women’s health.  Honored as a prominent reviewer for prestigious health journals .

🔬 Research Focus

Dr. Jenabi’s research primarily focuses on reproductive health, menopause, maternal and child care, and autism spectrum disorders. She is dedicated to advancing evidence-based practices in midwifery and women’s health through her ongoing studies and collaborations.

Conclusion

Ensiyeh Jenabi stands out as an accomplished researcher in reproductive health, making substantial contributions to both teaching and research at the Hamadan University of Medical Sciences. Her work in the domains of maternal health, menopausal care, and autism spectrum disorders shows her dedication to improving public health. With continued efforts to expand her research network and collaboration, she is poised to make even greater strides in her field, making her a strong contender for the Best Researcher Award.

Publication Top Notes

  • Factors associated with in-hospital death in patients with nosocomial infections: a registry-based study using community data in western Iran
    • Year: 2020
    • Authors: S Khazaei, E Ayubi, E Jenabi, S Bashirian, M Shojaeian, L Tapak
    • Citation: 11
  • Placenta previa after prior abortion: a meta-analysis
    • Year: 2017
    • Authors: M Karami, E Jenabi
    • Citation: 11
  • The association between hot flushes and smoking in midlife women: a meta-analysis
    • Year: 2015
    • Authors: E Jenabi, J Poorolajal
    • Citation: 11
  • The environmental risk factors associated with ectopic pregnancy: An umbrella review
    • Year: 2023
    • Authors: E Jenabi, E Ayubi, S Khazaei, AR Soltanian, AM Salehi
    • Citation: 9
  • COVID-19 prevention behaviors among health staff: data from a large survey in the west of Iran
    • Year: 2021
    • Authors: S Bashirian, S Khazaei, M Barati, E Jenabi, AR Soltanian, S Shirahmadi, …
    • Citation: 9
  • Etiology and outcome of burns in Hamadan, Iran: a registry-based study
    • Year: 2019
    • Authors: S Khazaei, F Shirani, M Afshari, E Jenabi, Z Hamzei, M Torabi, T Bathaei
    • Citation: 9
  • Maternal Smoking and the Risk of Placenta Accreta Spectrum: A Systematic Review and Meta‐Analysis
    • Year: 2022
    • Authors: E Jenabi, AM Salehi, SZ Masoumi, A Maleki
    • Citation: 8
  • Reinforcement and Maintenance of Human Resources for Health Systems during Long‐Term Crises: A Systematic Review of Systematic Reviews
    • Year: 2021
    • Authors: AM Salehi, S Khazaei, M Masumi, F Shavandi, M Kavand, E Jenabi, …
    • Citation: 8
  • Assessment of mask-wearing adherence and social distancing compliance in public passengers in Hamadan, Iran, during the COVID-19 pandemic
    • Year: 2021
    • Authors: AR Soltanian, T Omidi, S Khazaei, S Bashirian, R Heidarimoghadam, …
    • Citation: 8
  • Effect of Vitamin E on Reduction of Muscle Pain in Students with Premenstrual Syndrome
    • Year: 2014
    • Authors: F Shabiri, E Jenabi
    • Citation: 8

 

 

Tao Yun | Molecular Pathogenesis | Best Researcher Award

Posted on by ScienceFather

Prof. Tao Yun | Molecular Pathogenesis | Best Researcher Award

Research, Institute of Animal Husbandry and Veterinary Sciences, Zhejiang Academy of Agricultural Sciences, China

Tao Yun, PhD, is a distinguished researcher at the Institute of Animal Husbandry and Veterinary Sciences, Zhejiang Academy of Agricultural Sciences, China. Specializing in animal virology, he leads innovative studies on emerging viral diseases in poultry and vaccine development. With over two decades of experience, he has earned recognition for his contributions to veterinary science, including impactful publications and prestigious awards. His research emphasizes translational virology, merging basic science with practical applications to advance disease prevention and control in waterfowl and other species.

Publication Profile

Scopus

🎓 Education

Undergraduate (1997-2001): Veterinary Medicine, Shihezi University. Master’s (2001-2004): Animal Genetics, Breeding, and Reproduction Science, Shihezi University.  PhD (2007-2010): Preventive Veterinary Medicine, Northwest A&F University

💼 Experience

Researcher: Zhejiang Academy of Agricultural Sciences. Postgraduate Tutor: Zhejiang A&F University. Group Leader: Studying waterfowl viral pathogens like NDRV and TMUV

🏆 Awards & Honors

151 Talent Projects: Third-level training personnel in Zhejiang Province. Science Advancement Awards: For Tembusu virus and Rabbit Hemorrhagic Disease research

🔬 Research Focus

Emerging viral diseases in waterfowl, including NDRV and TMUV.  Vaccine development using animal herpesvirus vectors. Diagnostic tools for viral pathogen detection

Conclusion

Dr. Tao Yun is an outstanding candidate for the Best Researcher Award, given his impactful and innovative work in animal virology. His research on emerging viral diseases and vaccine development has significantly advanced the field, benefiting both academia and the agricultural industry. With a focus on continuous growth and broader collaborations, Dr. Yun’s potential to contribute to veterinary sciences remains unparalleled.

Publication Top Notes

2024

  1. Infection with novel duck reovirus induces stress granule and methylation-mediated host translational shutoff in Muscovy ducklings
    Authors: Yun, T.; Hua, J.; Chen, L.; … Zhu, Y.; Zhang, C.
    Journal: Communications Biology, 7(1), 1549
    Citations: 0
  2. Single-cell transcriptional profiling reveals cell type-specific responses to duck reovirus infection in the Bursa of Fabricius of Cairna moschata
    Authors: Yun, T.; Hua, J.; Ye, W.; … Zheng, C.; Zhang, C.
    Journal: International Journal of Biological Macromolecules, 281, 136391
    Citations: 0
  3. Complete Genome Sequence and Construction of an Infectious Bacterial Artificial Chromosome Clone of a Virulent Duck Enteritis Virus Strain XJ
    Authors: Huo, S.-X.; Zhu, Y.-C.; Chen, L.; … Bao, E.-D.; Zhang, C.
    Journal: Transboundary and Emerging Diseases, 2024, 1746963
    Citations: 0
  4. Development of a multienzyme isothermal and lateral flow dipstick combination assay for the rapid detection of goose astrovirus II
    Authors: Zhu, Y.; Chen, L.; Xu, X.; … Wang, H.; Zhang, C.
    Journal: Frontiers in Cellular and Infection Microbiology, 14, 1424212
    Citations: 0

2023

  1. High expression of the classical swine fever virus (CSFV) envelope protein E2 by a single amino acid mutation and its embedded in the pseudorabies virus (PRV) vector for immunization
    Authors: Sun, Y.-Y.; Liu, K.-S.; Yun, T.; … Bao, E.-D.; Zhang, C.
    Journal: Virus Research, 331, 199111
    Citations: 1
  2. Study on the Protective Immunity Induced by Pseudotyped Baculovirus Expressing the E Protein of Tembusu Virus in Ducklings
    Authors: Ni, Z.; Yun, T.; Chen, L.; … Liu, G.; Zhang, C.
    Journal: Genes, 14(7), 1316
    Citations: 1
  3. Inactivation Performance of Pseudorabies Virus as African Swine Fever Virus Surrogate by Four Commercialized Disinfectants
    Authors: Ni, Z.; Chen, L.; Yun, T.; … Zhu, Y.; Zhang, C.
    Journal: Vaccines, 11(3), 579
    Citations: 0
  4. Recombinant pseudorabies virus (PRV) expressing stabilized E2 of classical swine fever virus (CSFV) protects against both PRV and CSFV
    Authors: Sun, Y.-Y.; Liu, K.-S.; Zhang, C.; … Yun, T.; Bao, E.-D.
    Journal: Antiviral Research, 211, 105548
    Citations: 5
  5. Distinct Whole Transcriptomic Profiles of the Bursa of Fabricius in Muscovy Ducklings Infected by Novel Duck Reovirus with Different Virulence
    Authors: Yun, T.; Hua, J.; Ni, Z.; … Zhu, Y.; Zhang, C.
    Journal: Viruses, 15(1), 111
    Citations: 2

2022

  1. Isolation and Pathogenicity of a Novel Goose Astrovirus from Overfed Adult Landaise Geese in China
    Authors: Zhu, Y.; Wang, H.; Hua, J.; … Bao, E.; Zhang, C.
    Journal: Viruses, 14(12), 2806
    Citations: 8

 

 

Ayrton Bangolo | Oncology | Best Researcher Award

Posted on by ScienceFather

Dr. Ayrton Bangolo | Oncology | Best Researcher Award

Dr at Hackensack University Medical Center, United States

Dr. Ayrton I. Bangolo, MBBS, MD, is a board-certified internal medicine physician and current Hematology and Oncology fellow at Hackensack University Medical Center, New Jersey. With extensive medical training spanning across multiple countries, he graduated from Tianjin Medical University in China with an MBBS and gained ECFMG certification after excelling in USMLE exams. Dr. Bangolo has held significant positions in various esteemed medical institutions, including a residency at Palisades Medical Center, NJ. He has showcased his expertise through clinical practice, externships, and observerships in internal medicine, endocrinology, nephrology, and interventional radiology. His dedication to research and community health has been recognized with accolades such as awards at HMH research day. Dr. Bangolo’s background is enriched with a global perspective, which contributes to his comprehensive approach to patient care and medical innovation.

Profile

Scholar

Education 🎓

Ph.D. Fellowship in Hematology and Oncology (2024-Present): Hackensack University Medical Center, NJ, enrolled in an ACGME-accredited program. Residency in Internal Medicine (2021-2024): Palisades Medical Center, North Bergen, NJ, successfully completed a full-term ACGME-accredited residency. Transitional Year Residency (2020-2021): Palisades Medical Center, NJ, completed with exemplary performance. MBBS Degree (June 2016): Tianjin Medical University, China, graduated with credentials equivalent to MD. USMLE Certification: Passed USMLE Steps 1, 2 CK, and 3 on the first attempt, affirming ECFMG certification and eligibility for medical licensure in the U.S. Externships and Observerships: Clinical experience at Endocrine Associates, Norton’s Suburban Hospital, and Ngaliema Clinic among others, contributing to multidisciplinary expertise in internal medicine and specialty areas.

 Experience 💼

Hematology and Oncology Fellow (2024-Present): Hackensack University Medical Center, NJ, contributing to advanced clinical research and patient care in an ACGME-accredited fellowship. Internal Medicine Residency (2021-2024): Palisades Medical Center, North Bergen, NJ, completed core rotations with a focus on comprehensive patient care. Transitional Year Residency (2020-2021): Provided care across multiple medical disciplines at Palisades Medical Center, NJ. Externship in Endocrinology (2019-2020): Engaged in specialized practice under Dr. Hisham Alrefai at Endocrine Associates, KY. Observership in Nephrology (2019): Gained nephrology insights with Dr. Mohammed El Kheir at Norton’s Suburban Hospital, KY. Interventional Radiology Observership (2019): Participated under Dr. Mahmoud Samman, contributing to a deeper understanding of interventional procedures. Clinical Clerkship (2015-2016): Acquired foundational medical practice skills at Ngaliema Clinic, DR Congo.

Awards and Honors 🏆

2nd Place Research Poster: Honored for the study “Racial/Ethnic and Socioeconomic Differences in Colon Cancer Surgery” during the HMH North Region Fellow/Residents Research Day. UN Sustainable Development Goals Contribution: Published impactful research with Elsevier (2019-2021), emphasizing global health initiatives. Recognition for Excellence: Commended for clinical contributions during externships and observerships in Kentucky. Top Medical Graduate: Recognized as a distinguished graduate from Tianjin Medical University. USMLE Success: Passed all USMLE examinations on the first attempt, underscoring strong academic and practical medical knowledge.

Research Focus 🔍

Hematology & Oncology: Ongoing research in treatment protocols and health disparities, focusing on patient outcomes and innovative care practices. Racial and Socioeconomic Health Disparities: Investigated disparities in surgical treatments for colon cancer, contributing to policy discussions and medical strategies. Global Health Contributions: Published research aligning with United Nations’ goals, influencing international health practices. Medical Imaging & Diagnostics: Explored advancements in imaging for early disease detection and effective management. Endocrinology & Nephrology: Applied deep learning to medical data for better diagnostic outcomes and patient treatment plans. Patient Care & Clinical Innovation: Emphasizes integrative methods in patient treatment, fostering evidence-based and empathetic healthcare practices.

Conclusion 📝

Dr. Ayrton I. Bangolo’s proven track record in clinical practice, research contributions, and scholarly publications position him as a strong contender for the Best Researcher Award. His focus on impactful research and addressing health disparities is commendable. By expanding his research collaborations and further emphasizing his mentorship roles, Dr. Bangolo’s candidacy would be even more compelling.

Publications 📚

  • Title: Ultrasound performance using the EU-TIRADS score in the diagnosis of thyroid cancer in Congolese hospitals
    Authors: J Bukasa-Kakamba, P Bayauli, N Sabbah, J Bidingija, A Atoot, B Mbunga, …
    Year: 2022
    Journal: Scientific Reports 12 (1), 18442
    Citations: 9

 

  • Title: Racial/ethnic and socioeconomic differences in breast cancer surgery performed and delayed treatment: mediating impact on mortality
    Authors: P Fwelo, KOS Nwosu, TE Adekunle, O Afolayan, O Ahaiwe, AA Ojaruega, …
    Year: 2023
    Journal: Breast Cancer Research and Treatment 199 (3), 511-531
    Citations: 7

 

  • Title: Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States
    Authors: D Lew, F Kamal, K Phan, K Randhawa, S Cornwell, AI Bangolo, …
    Year: 2022
    Journal: World Journal of Clinical Oncology 13 (11), 907
    Citations: 7

 

  • Title: Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights
    Authors: AI Bangolo, C Trivedi, I Jani, S Pender, H Khalid, B Alqinai, A Intisar, …
    Year: 2023
    Journal: World Journal of Gastroenterology 29 (25), 3984
    Citations: 6

 

  • Title: Primary cardiac sarcoma: clinical characteristics and prognostic factors over the past 2 decades
    Authors: A Bangolo, P Fwelo, KM Iyer, S Klinger, L Tavares, S Dey, AA Chacko, …
    Year: 2023
    Journal: Diseases 11 (2), 74
    Citations: 6

 

  • Title: The overall quality of evidence of recommendations surrounding nutrition and diet in inflammatory bowel disease
    Authors: S Weissman, BM Fung, A Bangolo, A Rashid, BF Khan, AKG Tirumala, …
    Year: 2023
    Journal: International Journal of Colorectal Disease 38 (1), 98
    Citations: 6

 

  • Title: The Spectrum of Thyroid Nodules at Kinshasa University Hospital, Democratic Republic of Congo: A Cross-Sectional Study
    Authors: JK Bukasa, P Bayauli-Mwasa, BK Mbunga, A Bangolo, W Kavula, …
    Year: 2022
    Journal: International Journal of Environmental Research and Public Health 19 (23), 16203
    Citations: 6

 

  • Title: Outcomes of patients with gastrointestinal stromal tumors in the past decade
    Authors: A Bangolo, P Fwelo, T Al-Qatish, J Bukasa-Kakamba, T Lee, AG Cayago, …
    Year: 2023
    Journal: Medical Sciences 11 (3), 54
    Citations: 5

 

goto kyosuke | Medicine| Best Researcher Award

Posted on by ScienceFather

Mr. goto kyosuke | Medicine | Best Researcher Award

Mr at Fukuoka University, Japan

Kyosuke Goto is a physical therapist specializing in sports rehabilitation and research on sports injuries. Currently a PhD student at Fukuoka University’s Graduate School of Sports and Health Science, Goto has been an integral part of the Department of Rehabilitation at Fukuoka University Hospital since 2012, focusing on the sports rehabilitation team. His research contributions, particularly in sports-related concussions, have been published widely, influencing rehabilitation practices.

Profile

Scopus

Education 🎓

Goto holds a Bachelor of Physical Therapy from Teikyo University of Faculty of Medical Technology, Japan (2012). He is currently pursuing his PhD at Fukuoka University’s Graduate School of Sports and Health Science, which reflects his dedication to advancing his expertise in sports rehabilitation and injury research.

Experience 🧑‍🏫

Since April 2012, Goto has worked in the Department of Rehabilitation at Fukuoka University Hospital, contributing significantly to the Sports Rehabilitation Team. His role focuses on rehabilitation for athletes, assisting with recovery from injuries and optimizing their performance, while continuously refining techniques for injury prevention.

Awards and Honors 🏆

Goto has received notable recognition for his research, with multiple publications in esteemed journals such as Brain Science and Assistive Technology. His innovative contributions, particularly in concussion research and rehabilitation methods, have established him as a leading expert in the field of sports rehabilitation.

Research Focus 🔍

Goto’s research primarily revolves around sports-related injuries, with a strong emphasis on concussions and innovative rehabilitation techniques. He has explored the epidemiology of concussions in university athletes and the application of Hybrid Assistive Limb technology in rehabilitation following surgeries like total knee and hip arthroplasties.

Conclusion📝

Kyosuke Goto is undoubtedly a strong contender for the Best Researcher Award. His contributions to sports rehabilitation, particularly in the area of concussions, demonstrate both a deep understanding of the clinical challenges faced by athletes and a commitment to improving their recovery processes. Goto’s research has the potential to influence sports injury prevention and rehabilitation protocols worldwide, and his use of innovative technologies like HAL highlights his forward-thinking approach. With some expansion in the scope of his research and further collaborations, Kyosuke Goto has the potential to make even greater strides in enhancing the quality of care for athletes.

Publications 📚

  1. Title: Characteristics of Intracranial Kinetic Loads When Sports-Related Concussion Occurs in Men’s Rhythmic Gymnastics
    Year: 2024
    Authors: Otsubo, S., Shigemori, Y., Endo, S., Masuda, K., Zhang, Y.
    Source: Brain Sciences, 14(8), 835

 

  1. Title: Epidemiology of Sports-Related Concussion in Japanese University Soccer Players
    Year: 2024
    Authors: Fukushima, H., Shigemori, Y., Otsubo, S., Tsurusaki, R., Inui, M.
    Source: Brain Sciences, 14(8), 827

 

  1. Title: The Significance of Off-Season Tailor-Made Baseline Measurements in the Assessment of Post-Concussion in University Athletes
    Year: 2024
    Authors: Goto, K., Shigemori, Y., Tanabe, Y., Shimozono, H., Murakami, J.
    Source: Brain Sciences, 14(7), 698

 

  1. Title: Survey on Sports-Related Concussions Among Japanese University Students
    Year: 2022
    Authors: Otsubo, S., Shigemori, Y., Fukushima, H., Yamaguchi, K., Otsuka, N.
    Source: Brain Sciences, 12(11), 1557

 

  1. Title: Hybrid Assistive Limb Improves Restricted Hip Extension After Total Hip Arthroplasty
    Year: 2022
    Authors: Setoguchi, D., Kinoshita, K., Kamada, S., Inoue, T., Yamamoto, T.
    Source: Assistive Technology, 34(1), 112–120

 

  1. Title: Feasibility of Rehabilitation Using the Single-Joint Hybrid Assistive Limb to Facilitate Early Recovery Following Total Knee Arthroplasty: A Pilot Study
    Year: 2017
    Authors: Goto, K., Morishita, T., Kamada, S., Sankai, Y., Inoue, T.
    Source: Assistive Technology, 29(4), 197–201

Samira Al-Nasser | Medical/AI Engineering | Young Scientist Award

Posted on by ScienceFather

Dr. Samira Al-Nasser | Medical/AI Engineering | Young Scientist Award

Researcher at Bournemouth University,  United Kingdom

Dr. Samira Al-Nasser is an accomplished engineering professional and educator with a strong background in biomedical engineering and a focus on integrating machine learning for healthcare applications. Currently, as an Engineering Manager at Testlink, she leads a team specializing in ATM repair and design, while her research focuses on advanced sensor technology for joint load balancing during knee replacements. Dr. Al-Nasser has extensive experience in academia, holding positions as a Lecturer and Demonstrator at Bournemouth University. She is also actively involved in the Women in STEM Society and holds leadership roles promoting diversity in STEM.

Profile

Orcid

Scholar

Education 🎓

Dr. Al-Nasser earned a Ph.D. from Bournemouth University, focusing on the design and validation of load sensors for joint replacements, applying skills across mechanical and electrical engineering, machine learning, and material sciences. She previously graduated with first-class honors (84.2%) in Biomedical Engineering from German Jordanian University, specializing in biomedical instrumentation and signal processing. Her academic journey reflects a dedication to merging engineering principles with medical technology to improve patient outcomes, a commitment she continues through publications and research initiatives.

Experience 💼

Dr. Al-Nasser’s career spans various roles, including her current position as Engineering Manager at Testlink, where she manages teams in ATM repair. Previously, she was a Lecturer and Demonstrator at Bournemouth University, focusing on design simulation and lab instruction. Her early career includes research assistant roles and biomedical internships at Abdali Medical Center and The Specialty Hospital in Jordan, where she supported medical equipment maintenance and installations. These roles underscore her diverse expertise in engineering management, education, and applied medical research.

Awards and Honors 🏆

Dr. Al-Nasser has been recognized for her contributions to engineering and diversity, receiving the AdvanceHE Associate Fellowship for Teaching, which highlights her academic impact. She serves as a PGR Representative for the Athena SWAN Charter on Diversity and Inclusion and is an active member of the Women in STEM Society at Bournemouth University. Her accolades include awards for outstanding academic presentations at conferences, showcasing her dedication to advancing biomedical engineering and diversity in the engineering field.

Research Focus 🔍

Dr. Al-Nasser’s research centers on AI applications in orthopedic engineering, particularly in designing intelligent sensors for intraoperative load balancing during knee replacements. She investigates piezoelectric sensor technologies and machine learning-based load prediction models to enhance joint stability and improve surgical outcomes. Her work combines biomechanics, AI-driven signal processing, and biomedical device innovation, aiming to elevate precision in joint replacement surgeries and contribute to the broader field of smart healthcare technology.

Conclusion 🏆

Dr. Samira Al-Nasser is a strong contender for the Young Scientist Award. Her unique blend of research achievements, interdisciplinary expertise, and dedication to diversity and teaching makes her a rising star in biomedical engineering. With further growth in her collaborative network and research funding, Dr. Al-Nasser has the potential to make significant contributions to medical device innovation and healthcare technology. She exemplifies the qualities of a young scientist capable of driving impactful advancements in both academic and applied research domains.

Publications Top Notes

  1. Gait analysis of a kinematic retaining implant for Total knee replacements during walking and running
    • Journal: Journal of Orthopaedics
    • Date: 2024-10
    • DOI: 10.1016/j.jor.2024.02.025
    • Contributors: Adrian Harvey, Suraj Kohli, Samira Al-Nasser, Siamak Noroozi

 

  1. WITHDRAWN: Cadaveric Testing of a Novel Intraoperative Load Sensor for Soft-tissue balancing during Total Knee Replacements
    • Journal: Journal of Orthopaedic Reports
    • Date: 2024-07
    • DOI: 10.1016/j.jorep.2024.100448
    • Contributors: Samira Al-Nasser, Saimak Noroozi, Adrian Harvey, Roya Haratian

 

  1. Design of a Novel Intraoperative Sensor for Load Balancing and Tracking during Total Knee Replacements

 

  1. Exploring the Performance of an Artificial Intelligence-Based Load Sensor for Total Knee Replacements
    • Journal: Sensors
    • Date: 2024-01-17
    • DOI: 10.3390/s24020585
    • Contributors: Samira Al-Nasser, Siamak Noroozi, Adrian Harvey, Navid Aslani, Roya Haratian